Immune checkpoint inhibitor-related epidermal necrolysis: A rare condition with poor prognosis

Eur J Cancer. 2021 Mar:145:194-196. doi: 10.1016/j.ejca.2020.12.018. Epub 2021 Jan 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects*
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Skin / drug effects*
  • Skin / pathology
  • Stevens-Johnson Syndrome / diagnosis
  • Stevens-Johnson Syndrome / etiology*
  • Stevens-Johnson Syndrome / mortality
  • Stevens-Johnson Syndrome / therapy

Substances

  • Immune Checkpoint Inhibitors